|
Category: antistatic, emollient agents
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
| Assay: | 95.00 to 100.00 %
|
| Food Chemicals Codex Listed: | No |
| Boiling Point: | 669.61 °C. @ 760.00 mm Hg (est)
|
| Flash Point: | 364.00 °F. TCC ( 184.60 °C. ) (est)
|
| logP (o/w): | 15.997 (est) |
| Soluble in: |
| | water, 4.78e-011 mg/L @ 25 °C (est) |
Organoleptic Properties:
| |
| Odor and/or flavor descriptions from others (if found). |
| |
| |
Cosmetic Information:
Suppliers:
Safety Information:
| Preferred SDS: View |
| |
| Hazards identification |
| |
| Classification of the substance or mixture |
| GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
| None found. |
| GHS Label elements, including precautionary statements |
| |
| Pictogram | |
| |
| Hazard statement(s) |
| None found. |
| Precautionary statement(s) |
| None found. |
| Oral/Parenteral Toxicity: |
|
Not determined
|
| Dermal Toxicity: |
|
Not determined
|
| Inhalation Toxicity: |
|
Not determined
|
Safety in Use Information:
| Category: | antistatic, emollient agents |
| Recommendation for distearin usage levels up to: | | | not for fragrance use.
|
| |
| Recommendation for distearin flavor usage levels up to: |
| | not for flavor use.
|
Safety References:
References:
Other Information:
Potential Blenders and core components note
Potential Uses:
| | antistatic agents | |
| | emollients | |
Occurrence (nature, food, other): note
Synonyms:
| | cithrol gds n/e | | | distearic acid, diester with glycerol | | | distearin | | | distearoylglycerol mixed isomers | | | glycerine distearate | | | hallstar GDS | | (2- | hydroxy-3-octadecanoyloxypropyl) octadecanoate | | 2- | hydroxypropane-1,3-diyl dioctadecanoate | | 2- | hydroxypropane-1,3-diyl distearate | | | nikkol DGS-80 | | | octadecanoic acid, 2-hydroxy-1,3-propanediyl ester | | | octadecanoic acid, diester with 1,2,3-propanetriol | | | stearic acid diglycerin ester |
Articles:
| PubMed: | PEG-Stabilized Bilayer Nanodisks As Carriers for Doxorubicin Delivery. |
| PubMed: | Formulation and characterization of nanostructured lipid carrier of ubiquinone (Coenzyme Q10). |
| PubMed: | Amended final report on the safety assessment of glyceryl dilaurate, glyceryl diarachidate, glyceryl dibehenate, glyceryl dierucate, glyceryl dihydroxystearate, glyceryl diisopalmitate, glyceryl diisostearate, glyceryl dilinoleate, glyceryl dimyristate, glyceryl dioleate, glyceryl diricinoleate, glyceryl dipalmitate, glyceryl dipalmitoleate, glyceryl distearate, glyceryl palmitate lactate, glyceryl stearate citrate, glyceryl stearate lactate, and glyceryl stearate succinate. |
| PubMed: | Testosterone solid lipid microparticles for transdermal drug delivery. Formulation and physicochemical characterization. |
| PubMed: | [Analysis of constituents in urushi wax, a natural food additive]. |
| PubMed: | In vitro study on sustained release capsule formulation of acetazolamide. |
| PubMed: | Liposomes as a topical delivery system: the role of size on transport studied by the EPR imaging method. |
| PubMed: | Influence of nonionic liposomal composition on topical delivery of peptide drugs into pilosebaceous units: an in vivo study using the hamster ear model. |
|